STORM Therapeutics Pioneering New RNA Pathways to Novel Therapies

“New technologies like RNA inhibitors that alter the genetic drivers of a disease, have the potential to transform medicine…”

Giulio Cerroni, CEO and Grant Nash CFO of IXICO (IXI)

Listen to Ixico’s interview on Vox Market’s daily podcast with Justin Waite. Forward to 23:00 minutes to hear them discuss their growth…

© Optimum Strategic Communications.